Effect of Using the HEART Score in Patients With Chest Pain in the Emergency Department: A Stepped-Wedge, Cluster Randomized Trial

Autor: Bernard J.W.M. Rensing, Hendrik Koffijberg, Roland R.J. van Kimmenade, Ghizelda R. Lagerweij, Rolf F. Veldkamp, Maarten J. Cramer, Madelon van den Heuvel, Johannes B. Reitsma, A. Jacob Six, Judith M. Poldervaart, Barbra E. Backus, Nicolette M.S.K.J. Ernst, Clara E.E. van Ofwegen-Hanekamp, Arno W. Hoes, Herman F.J. Mannaerts, Ineke M.C. Dekker, Mohamed el Farissi, Pieter A. Doevendans, Marcel A.J. Landman, Jan Melle van Dantzig, Jeroen J.J. Bucx, Yolande Appelman, Maarten W. J. van Hessen, Monique E. ten Haaf, Frank R. den Hartog, Luc Cozijnsen, Thomas Oosterhof, Eugene M. Buijs
Přispěvatelé: Health Technology & Services Research, Cardiology, ACS - Atherosclerosis & ischemic syndromes, ACS - Microcirculation
Rok vydání: 2017
Předmět:
Male
medicine.medical_specialty
Chest Pain
Cost-Benefit Analysis
Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]
Coronary Disease
030204 cardiovascular system & hematology
Chest pain
Risk Assessment
law.invention
03 medical and health sciences
Electrocardiography
0302 clinical medicine
Quality of life (healthcare)
Randomized controlled trial
law
Risk Factors
Health care
Internal Medicine
medicine
Journal Article
Humans
030212 general & internal medicine
Cluster randomised controlled trial
Prospective Studies
Prospective cohort study
Medical History Taking
business.industry
Incidence (epidemiology)
Age Factors
General Medicine
Emergency department
Middle Aged
Troponin
Emergency medicine
Randomized Controlled Trial
Female
medicine.symptom
Health Expenditures
business
Emergency Service
Hospital
Zdroj: Poldervaart, J M, Reitsma, J B, Backus, B E, Koffijberg, H, Veldkamp, R F, Ten Haaf, M E, Appelman, Y, Mannaerts, H F J, Van Dantzig, J M, Van Den Heuvel, M, El Farissi, M, Rensing, B J W M, Ernst, N M S K J, Dekker, I M C, Den Hartog, F R, Oosterhof, T, Lagerweij, G R, Buijs, E M, Van Hessen, M W J, Landman, M A J, Van Kimmenade, R R J, Cozijnsen, L, Bucx, J J J, Van Ofwegen-Hanekamp, C E E, Cramer, M J, Six, A J, Doevendans, P A & Hoes, A W 2017, ' Effect of using the HEART score in patients with chest pain in the emergency department : A Stepped-wedge, cluster randomized trial ', Annals of Internal Medicine, vol. 166, no. 10, pp. 689-697 . https://doi.org/10.7326/M16-1600
Annals of Internal Medicine, 166(10), 689. American College of Physicians
Annals of Internal Medicine, 166(10), 689-697. American College of Physicians
Annals of Internal Medicine C.2, 166, 689-697
Annals of Internal Medicine C.2, 166, 10, pp. 689-697
ISSN: 0003-4819
DOI: 10.7326/M16-1600
Popis: Item does not contain fulltext Background: The HEART (History, Electrocardiogram, Age, Risk factors, and initial Troponin) score is an easy-to-apply instrument to stratify patients with chest pain according to their short-term risk for major adverse cardiac events (MACEs), but its effect on daily practice is unknown. Objective: To measure the effect of use of the HEART score on patient outcomes and use of health care resources. Design: Stepped-wedge, cluster randomized trial. (ClinicalTrials.gov: NCT01756846). Setting: Emergency departments in 9 Dutch hospitals. Patients: Unselected patients with chest pain presenting at emergency departments in 2013 and 2014. Intervention: All hospitals started with usual care. Every 6 weeks, 1 hospital was randomly assigned to switch to "HEART care," during which physicians calculated the HEART score to guide patient management. Measurements: For safety, a noninferiority margin of a 3.0% absolute increase in MACEs within 6 weeks was set. Other outcomes included use of health care resources, quality of life, and cost-effectiveness. Results: A total of 3648 patients were included (1827 receiving usual care and 1821 receiving HEART care). Six-week incidence of MACEs during HEART care was 1.3% lower than during usual care (upper limit of the 1-sided 95% CI, 2.1% [within the noninferiority margin of 3.0%]). In low-risk patients, incidence of MACEs was 2.0% (95% CI, 1.2% to 3.3%). No statistically significant differences in early discharge, readmissions, recurrent emergency department visits, outpatient visits, or visits to general practitioners were observed. Limitation: Physicians were hesitant to refrain from admission and diagnostic tests in patients classified as low risk by the HEART score. Conclusion: Using the HEART score during initial assessment of patients with chest pain is safe, but the effect on health care resources is limited, possibly due to nonadherence to management recommendations. Primary Funding Source: Netherlands Organisation for Health Research and Development.
Databáze: OpenAIRE